Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/190351
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAmorós-Galicia, Lola-
dc.contributor.authorNardi Ricart, Anna-
dc.contributor.authorVerdugo-González, Clara-
dc.contributor.authorArroyo-García, Carmen Martina-
dc.contributor.authorGarcía Montoya, Encarna-
dc.contributor.authorPérez Lozano, Pilar-
dc.contributor.authorSuñé i Negre, Josep M. (Josep Maria)-
dc.contributor.authorSuñé Pou, Marc-
dc.date.accessioned2022-10-31T13:42:18Z-
dc.date.available2022-10-31T13:42:18Z-
dc.date.issued2022-09-21-
dc.identifier.issn1999-4923-
dc.identifier.urihttp://hdl.handle.net/2445/190351-
dc.description.abstractAlthough some methods for measuring bioadhesion/mucoadhesion have been proposed, a standardized method is not yet available. This is expected to hinder systematic comparisons of results across studies. This study aimed to design a single/systematic in vitro method for measuring bioadhesion/mucoadhesion that is applicable to various pharmaceutical dosage forms. To this end, we measured the peak force and work of adhesion of minitablets, pellets, and a bioadhesive emulsion using a texture analyzer. Porcine tissue was used to simulate human stomach/skin conditions. The results of these formulations were then compared to those for formulations without the bioadhesive product. We conducted a case study to assess the stability of a bioadhesive emulsion. The results for the two parameters assessed were contact time = 60 s and contact force = 0.5 N at a detachment speed of 0.1 mm/s. Significant differences were observed between the bioadhesive and control formulations, thus demonstrating the adhesive capacity of the bioadhesive formulations. In this way, a systematic method for assessing the bioadhesive capacity of pharmaceutical dosage forms was developed. The method proposed here may enable comparisons of results across studies, i.e., results obtained using the same and different pharmaceutical formulations (in terms of their bioadhesion/mucoadhesion capacity). This method may also facilitate the selection of potentially suitable formulations and adhesive products (in terms of bioadhesive properties).-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/pharmaceutics14101995-
dc.relation.ispartofPharmaceutics, 2022-
dc.rightscc-by (c) Amorós-Galicia, Lola et al., 2022-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)-
dc.subject.classificationMembrana mucosa-
dc.subject.classificationAdministració de medicaments-
dc.subject.otherMucous membrane-
dc.subject.otherAdministration of drugs-
dc.titleDevelopment of a Standardized Method for Measuring Bioadhesion and Mucoadhesion That Is Applicable to Various Pharmaceutical Dosage Forms-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec725917-
dc.date.updated2022-10-31T13:42:18Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
725917.pdf1.52 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons